This disclosure relates generally to prosthetic valves and delivery systems for prosthetic valves. More specifically, this disclosure relates to delivery systems for implantation of prosthetic valves and methods thereof.
The native heart valves (the tricuspid valve, pulmonary valve, mitral valve, and aortic valve) play an important role in regulating flow of blood through the cardiovascular system. However, the native heart valves may become damaged or impaired, such as due to cardiovascular diseases, infections, or congenital malformations, thus limiting the ability of the native heart valves to regulate blood flow. This deficiency may result in reduced cardiovascular function or even death.
To treat these conditions, prosthetic heart valves may be implanted at or near the site of a damaged or impaired native valve. A prosthetic heart valve may assist or replace the functionality of an impaired native valve, leading to better regulation of blood flow and improved cardiovascular function. However, many existing prosthetic heart valves require implantation via an open heart procedure, which is highly-invasive and may cause life-threatening complications. Other prosthetic valves may be collapsed within a prosthetic valve delivery system and advanced into the heart, at which point the prosthetic valve may be removed from the delivery system and expanded at the native valve site. However, many of these prosthetic valves are large in size and therefore difficult to deliver into the heart without causing damage to healthy tissue along the implantation route. In addition, once these prosthetic valves are situated within the heart, they may be difficult to securely implant at the native valve site due to their complex structure and the limited maneuverability of existing prosthetic valve delivery systems within the heart. Moreover, many prosthetic valves are so large that they may protrude several centimeters into surrounding heart chambers once they are implanted, impairing cardiac filling and causing injury to the anatomy within the heart.
Thus, there remains a need for prosthetic heart valves that are smaller in size yet still configured to assist or replace the functionality of a diseased or damaged native heart valve. In addition, there remains a need for prosthetic heart valves that are more easily maneuvered into the heart and securely implanted at the site of a native heart valve. Moreover, there remains a need for improved prosthetic heart valve delivery systems that are configured to securely implant a prosthetic heart valve at an implantation site. The present disclosure provides prosthetic heart valves with a reduced axial length such that the prosthetic heart valves may be more easily delivered into the heart and may exhibit lower protrusion into the chambers of the heart. The present disclosure also provides improved prosthetic heart valve delivery systems and methods of implanting prosthetic heart valves therewith, such that prosthetic heart valves may be securely anchored at the implantation site.
Disclosed herein are systems and methods for implantation of prosthetic valves by prosthetic valve delivery systems. Particular examples of the disclosure may pertain to a prosthetic valve delivery system configured for multi-planar steering and having a delivery capsule configured to retain a prosthetic valve therein.
According to an exemplary embodiment of the present disclosure, a prosthetic valve delivery system is provided. The prosthetic valve delivery system includes a first catheter, a first steering mechanism, a second catheter, a second steering mechanism, and a capsule. The first steering mechanism is configured to bend the first catheter within a first steering plane. The second catheter is coaxially arranged within the first catheter. The second steering mechanism is configured to bend the second catheter within a second steering plane. The second steering plane is different from the first steering plane. The capsule is positioned distal to both the first catheter and the second catheter. The capsule is configured to retain a prosthetic valve therein during transvascular advancement.
The first steering plane is orthogonal to the second steering plane. The first catheter is configured to remain substantially straightened while the second catheter bends within the second steering plane. The first catheter and the second catheter are each configured to bend by an angle greater than 90°. The first catheter and the second catheter are each configured to bend by an angle no greater than 120°. The prosthetic valve delivery system additionally includes a third catheter coaxially arranged within the second catheter. The capsule is connected to the third catheter. At least a portion of the capsule is configured for longitudinal movement relative to the third catheter. The first catheter, the second catheter, and the third catheter are all configured for relative longitudinal movement. The first catheter and the second catheter are configured to bend the third catheter by an angle greater than 180°. The capsule includes a distal capsule portion and a proximal capsule portion. The distal capsule portion and the proximal capsule portion are configured for movement in opposing directions. The distal capsule portion is configured to retain a ventricular portion of the prosthetic valve therein. The proximal capsule portion is configured to retain an atrial portion of the prosthetic valve therein. The distal capsule portion is configured to retain an annular valve body of the prosthetic valve and a plurality of ventricular anchoring legs of the prosthetic valve therein. The proximal capsule portion is configured to retain a plurality of atrial anchoring arms of the prosthetic valve therein. The distal capsule portion is configured to release the ventricular anchoring legs while the annular valve body remains retained therein. The capsule further includes a valve anchor configured to secure the prosthetic valve during movement of one or more of the distal capsule portion and the proximal capsule portion. The prosthetic valve delivery system additionally includes a first capsule actuator and a second capsule actuator. The first capsule actuator is configured to effect longitudinal movement of the distal capsule portion relative to the valve anchor. The second capsule actuator is configured to effect longitudinal movement of the proximal capsule portion relative to the valve anchor. The first capsule actuator is configured to move the distal capsule portion to a first position in which a portion of the prosthetic valve is released from the capsule while the prosthetic valve remains secured relative to the capsule. The first capsule actuator is also configured to move the distal capsule portion to a second position in which the prosthetic valve is released from the capsule. The prosthetic valve delivery system additionally includes a handle configured to enable rotation of the first catheter and the second catheter. The prosthetic valve delivery system additionally includes a first catheter actuator and a second catheter actuator. The first catheter actuator is configured to effect bending of the first catheter within the first steering plane. The second catheter actuator is configured to effect longitudinal movement of the second catheter and bending of the second catheter within the second steering plane. The first catheter actuator and second catheter actuator are configured for relative longitudinal movement. The prosthetic valve delivery system additionally includes a catheter lock configured to prevent relative longitudinal movement of the first catheter and the second catheter. The first catheter and the second catheter are configured to advance the capsule through vasculature and across a fossa to position the prosthetic valve within a heart chamber.
Additional features and advantages of the disclosed embodiments will be set forth in part in the description that follows, and in part will be obvious from the description, or may be learned by practice of the disclosed embodiments. The features and advantages of the disclosed embodiments will be realized and attained by the elements and combinations particularly pointed out in the appended claims.
It is to be understood that both the foregoing general description and the following detailed description are examples and explanatory only and are not restrictive of the disclosed embodiments as claimed.
The accompanying drawings constitute a part of this specification. The drawings illustrate several embodiments of the present disclosure and, together with the description, serve to explain the principles of the disclosed embodiments as set forth in the accompanying claims.
Exemplary embodiments are described with reference to the accompanying drawings. In the figures, which are not necessarily drawn to scale, the left-most digit(s) of a reference number identifies the figure in which the reference number first appears. Wherever convenient, the same reference numbers are used throughout the drawings to refer to the same or like parts. While examples and features of disclosed principles are described herein, modifications, adaptations, and other implementations are possible without departing from the spirit and scope of the disclosed embodiments. Also, the words “comprising,” “having,” “containing,” and “including,” and other similar forms are intended to be equivalent in meaning and be open ended in that an item or items following any one of these words is not meant to be an exhaustive listing of such item or items, or meant to be limited to only the listed item or items. It should also be noted that as used in the present disclosure and in the appended claims, the singular forms “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.
In some embodiments of the present disclosure, an “atrial direction” may refer to a direction extending towards an atrium of the heart. For example, from a location within the left ventricle or the mitral valve, an atrial direction may refer to a direction extending towards the left atrium. Additionally, from a location within an atrium (e.g., the left atrium), an atrial direction may refer to a direction extending away from an adjacent atrioventricular valve (e.g., the mitral valve) and further into the atrium. For example, in
In some exemplary embodiments of the present disclosure, a “ventricular direction” may refer to a direction extending towards a ventricle of the heart. From a location within the left atrium or the mitral valve, a ventricular direction may refer to a direction extending towards the left ventricle. Additionally, from a location within a ventricle (e.g., the left ventricle), a ventricular direction may refer to a direction extending away from an adjacent atrioventricular valve (e.g., the mitral valve) and further into the ventricle. For example, in
Exemplary embodiments generally relate to prosthetic valves for implantation within a native valve and methods for implanting prosthetic valves within a native valve. In addition, exemplary embodiments generally relate to systems and methods for implantation of prosthetic valves by prosthetic valve delivery systems. While the present disclosure provides examples relating to prosthetic heart valves, and in particular prosthetic mitral valves, as well as delivery systems for prosthetic heart valves, it should be noted that aspects of the disclosure in their broadest sense are not limited to a prosthetic heart valve. Rather, the foregoing principles may be applied to other prosthetic valves as well. In various embodiments in accordance with the present disclosure, the term prosthetic valve refers generally to an implantable valve configured to restore and/or replace the functionality of a native valve, such as a diseased or otherwise impaired native heart valve.
An exemplary prosthetic valve may include a prosthetic valve configured to render a native valve structure non-functional, and may thus replace the function of the native valve. For example, an exemplary prosthetic valve may have a size and shape similar to the valve being replaced and may include a number of leaflet-like structures to regulate fluid flow and prevent backflow of blood through the valve. Additionally, or alternatively, an exemplary prosthetic valve may also include a prosthetic valve configured to leave the native valve structure intact and functional. An exemplary prosthetic valve may include a mitral valve, tricuspid valve, aortic valve, or pulmonary valve, as well as a valve outside of the heart, such as a venous valve, lymph node valve, ileocecal valve, or any other structure configured to control and/or regulate fluid flow in the body. An exemplary prosthetic valve may additionally or alternatively be configured to replace a failed bioprosthesis, such as a failed heart valve prosthesis.
Annular outer frame 1200 may include an outer frame tubular portion 1220, which may be formed of a plurality of struts intersecting at junctions to form a wire mesh, stent-like, or cage-like structure of the outer frame tubular portion 1220. Annular outer frame 1200 may also include at least one ventricular anchoring leg 1240, which may be configured to extend radially outward from the outer frame tubular portion and which may contact, or otherwise engage, tissue within or near the native valve to anchor the prosthetic valve within the native valve. In some embodiments, exemplary valve frame 1000 may include twelve ventricular anchoring legs 1240, which may be configured to engage ventricular tissue of a native atrioventricular valve.
Inner frame 1400 may include an inner frame tubular portion 1420, which may be formed of a plurality of struts intersecting at junctions to form a wire mesh, stent-like, or cage-like structure of the inner frame tubular portion 1420. Inner frame 1400 may also include at least one atrial anchoring arm 1440, which may be configured to extend radially outward from the inner frame tubular portion and which may contact, or otherwise engage, tissue within or near the native valve to anchor the prosthetic valve within the native valve. In some embodiments, exemplary valve frame 1000 may include twelve atrial anchoring arms 1440, which may be configured to engage atrial tissue of a native atrioventricular valve.
Outer frame tubular portion 1220 and inner frame tubular portion 1420 may together form an annular valve body 1020 of the prosthetic valve, which may have at least one opening and from which the ventricular anchoring legs 1240 and atrial anchoring arms 1440 may extend. Annular valve body 1020 may include an axial lumen 1022 extending through the annular valve body 1020 along a longitudinal axis 1800 of the prosthetic valve. In some embodiments, annular valve body 1020 may be configured to receive a flow control device, such as one or more prosthetic leaflets, within axial lumen 1022. Optionally, annular valve body 1020 may include one or more atrial end delivery posts 1027 along an atrial end (i.e., top end) of the annular valve body and/or one or more ventricular end delivery posts 1028 along a ventricular end (i.e., bottom end) of the annular valve body. Delivery posts 1027 and 1028 may be configured to removably engage a delivery device of the prosthetic valve, for example, to assist with placement of frame 1000 within or near a native valve.
Annular outer frame 2200 may include an outer frame tubular portion 3605, which may be formed of a plurality of struts intersecting at junctions to form a wire mesh, stent-like, or cage-like structure of the outer frame tubular portion 3605. For example, as illustrated in
Inner frame 2400 may include an inner frame tubular portion 3005, which may be formed of a plurality of struts intersecting at junctions to form a wire mesh, stent-like, or cage-like structure of the inner frame tubular portion 3005. For example, as illustrated in
Outer frame tubular portion 3605 and inner frame tubular portion 3005 may together form an annular valve body 2020 of the prosthetic valve, which may have at least one opening and from which the ventricular anchoring legs 2240 and atrial anchoring arms 2440 may extend. Annular valve body 2020 may include an axial lumen 2022 extending through the annular valve body 2020 along a longitudinal axis 2800 of the prosthetic valve. Annular valve body 2020 may have an atrial end 2024, a ventricular end 2025 opposite the atrial end, and an intermediate portion 2026 extending between the atrial and ventricular ends. In some embodiments, the atrial end may refer to the portion of the annular valve body configured to be situated at a location within the atrium that is furthest from an adjacent ventricle, when the prosthetic valve is implanted in a native valve. Similarly, the ventricular end may refer to the portion of the annular valve body configured to be situated at a location within the ventricle that is furthest from an adjacent atrim, when the prosthetic valve is implanted in a native valve. The intermediate portion 2026 may extend between the atrial end 2024 and ventricular end 2025. In some embodiments, annular valve body 2020 may include one or more ventricular end delivery posts 1028 along the ventricular end 2025 of the annular valve body. Axial lumen 2022 may include an inlet opening 2032 at the atrial end of the annular valve body, as well as an outlet opening 2036 at the ventricular end of the annular valve body.
In some embodiments, prosthetic valve 6000 may additionally include a protective sleeve 6102 wrapped around the rim 6800 of the ventricular outlet opening of annular valve body 2020; protective sleeve 6102 may be secured to annular valve body 2020 by stitching 6108. Additionally, or alternatively, prosthetic valve 6000 may include at least one liner 6310 extending around an external surface of the ventricular anchoring legs 2240, with at least one protective layer 6330 positioned around the distal leg ends 2244 and at least one protective covering 6320 wrapped around the proximal leg ends 3622. In some embodiments, the at least one protective covering 6320 may be secured to the skirt layer 6100 via stitching 6322.
Control handle assembly 7100 may include an outer sheath control handle 7120 having a steering knob 7122 configured to steer an outer sheath 7210 of the telescoping catheter assembly 7200. Control handle assembly 7100 may also include a guide catheter control handle 7140 having a steering knob 7142 configured to steer a guide catheter 7220 of the telescoping catheter assembly 7200.
Control handle assembly 7100 may also include an implant catheter control handle 7160 having a steering knob 7168 configured to steer an implant catheter 8100 of the telescoping catheter assembly 7200. Implant catheter control handle 7160 may also include a proximal capsule portion slider 7162, a distal capsule portion knob 7170, and a distal capsule portion knob lock 7172 configured to control release of the prosthetic valve 6000 from within delivery capsule 7300. Implant catheter control handle 7160 may also include a slide lock 7166 configured to lock the implant catheter control handle 7160 at a position within track 7420 of stand 7400.
Control handle assembly 7100 may also include a cradle 7180, which may be secured to stand 7400 via a locking mechanism that can be released by actuated of release button 7184. Cradle 7180 may include a rotation knob 7182 configured to control rotation of the outer sheath 7210 and guide catheter 7220. Cradle 7180 may also include a rotation knob 7186 configured to control rotation of the implant catheter 8100. Cradle 7180 may also include a knob 7188 configured to control relative axial movement between outer sheath control handle 7120 (which may be secured to outer sheath 7210) and guide catheter control handle 7140 (which may be secured to guide catheter 7220).
In the embodiment illustrated in
In
In
Various embodiments of the present disclosure relate to prosthetic valve delivery systems. While the present disclosure provides examples of prosthetic heart valve delivery systems, it should be noted that aspects of the disclosure in their broadest sense, are not limited to prosthetic heart valve delivery systems. Rather, it is contemplated that aspects of the present disclosure may be applied to delivery systems for other prosthetic or implantable devices as well and are not limited to delivery systems for prosthetic valves or heart valves. Prosthetic valve delivery system 7000 illustrated in
An exemplary prosthetic valve delivery system in accordance with the present disclosure may include one or more catheters configured to approach the heart transfemorally, transapically, transatrially, transseptally, or transjugularly. The one or more catheters may be configured to position the prosthetic valve, which may be retained within the delivery system, in or near the native valve orifice such that the prosthetic valve may be released from the delivery system within or near the native valve. As used herein, the term “catheter” may denote an elongated, tubular structure that may be selectively flexible along a length of the elongated structure. The one or more catheters can be manufactured from a variety of suitable, biocompatible materials, some non-limiting examples including silicone Pebax, rubber, nylon, polyurethane, polyethylene terephthalate (PET), latex, thermoplastic elastomers, silicone, and polyimides. The one or more catheters may be sufficiently flexible such that they may be configured to pass through tortuous anatomy (e.g., blood vessels and heart chambers) without sustaining damage or injuring the native tissue during delivery of the catheter to the implantation site. The one or more catheters of the exemplary prosthetic valve delivery system may be at least long enough to extend from a location outside of a patient's body to a site within the heart. The one or more catheters may be configured as a one-size-fits all, a range of sizes depending on the size of the patient or may be fully customizable. Exemplary sizes of the one or more catheters may include between 6 French (Fr) and 40 Fr, between 20 Fr and 35 Fr, between 27 Fr and 33 Fr. The one or more catheters may have any appropriate length, for example between 1 millimeter (mm) and 1 meter (m), between 1 mm and 2 m, between 1 mm and 3 m, or longer, such the one or more catheters are at least long enough to extend from a location outside of the patient's body to a site within the heart.
In some embodiments, the one or more catheters of the exemplary prosthetic valve delivery system may include a first catheter. In some embodiments, the first catheter may be the outer-most catheter of the delivery system. Alternatively, the first catheter may be received within another catheter or tubular structure. Outer sheath 7210 illustrated in
An exemplary prosthetic valve delivery system may include a first steering mechanism configured to bend the first catheter within a first steering plane. As used herein, the term “bend” may refer to the shaping or forcing the first catheter from a straight configuration into a curved or angled configuration, or from a curved or angled configuration back to a straight configuration or into a different curved or angled configuration. In some embodiments, the first steering mechanism may be actuated by a user to effect bending of the first catheter within the first steering plane. For example, the first steering mechanism may be incorporated within a control handle assembly (e.g., control handle assembly 7100 depicted in
In some embodiments, the first catheter may include at least one portion configured to bend relative to the rest of the first catheter within the first steering plane, under the control of the first steering mechanism. Bending portion 7215 illustrated in
As discussed above, an exemplary prosthetic valve delivery system in accordance with the present disclosure may include one or more catheters. In some embodiments, the prosthetic valve delivery system may include a second catheter coaxially arranged within the first catheter. The second catheter may be situated at least partially within the first catheter and may be configured for axial movement relative to the first catheter. In some embodiments, the second catheter may be the inner-most catheter of the prosthetic valve delivery system. Alternatively, one or more tubular structures may be situated at least partially within the second catheter.
An exemplary prosthetic valve delivery system may include a second steering mechanism configured to bend the second catheter within a second steering plane different from the first steering plane. In some embodiments, the second steering mechanism may be actuated by a user to effect bending of the second catheter within the second steering plane. For example, the second steering mechanism may be incorporated within a control handle assembly (e.g., control handle assembly 7100 depicted in
In some embodiments, the second catheter may include at least one portion configured to bend relative to the rest of the second catheter within the second steering plane, under the control of the second steering mechanism. Bending portion 7225 illustrated in
In some embodiments, an exemplary prosthetic valve delivery system may include a capsule positioned distal to both the first catheter and the second catheter. A proximal end of the prosthetic valve delivery system may refer to a point or a location along the length of the delivery system closer to a physician or a medical practitioner. A distal end of the prosthetic valve delivery system may refer to a point or a location along the length of the delivery system closer to an implantation or treatment site in the body of a patient during implantation of a prosthetic valve. The capsule may be a hollow structure, such as a vessel, container, receptacle, or the like, which can be configured to hold the prosthetic valve at least partially therein. The capsule may have multiple parts configured to move relative to each other so as to selectively retain and release the valve. In some embodiments, the capsule may be positioned distal to the distal ends of the first and second catheters. The capsule may be configured to retain a prosthetic valve therein and to deliver the prosthetic valve through the anatomy (e.g., vasculature) to the prosthetic valve implantation site. That is, the capsule may be configured to retain the prosthetic valve therein during transvascular advancement of the capsule. In some embodiments, the capsule may be configured to retain the prosthetic valve in a radially-contracted configuration, such that the prosthetic valve may easily pass through the anatomy during delivery to the implantation site. In the example depicted in
In some exemplary prosthetic valve delivery systems, the first and second catheters may be configured such that the first steering plane may be orthogonal to the second steering plane. “Orthogonal” may mean of or involving right angles. Accordingly, the first steering plane and the second steering plane can be positioned at right angles with respect to each other. Additionally, or alternatively, the first steering plane and the second steering plane can be positioned at acute angles with respect to each other (e.g., angles less than 90°). For example, in some embodiments, the first steering plane may be configured to be positioned at an angle of between 30° and 89°, relative to the second steering plane. Furthermore, the first steering plane and the second steering plane can be positioned at obtuse angles with respect to each other (e.g., angles greater than 90°.
In some exemplary embodiments, the first catheter may be configured to remain substantially straightened while the second catheter bends within the second steering plane. In some embodiments, the bending portion of the second catheter can extend beyond the distal end of the first catheter, where bending of the bending portion of the second catheter does not cause bending of the bending portion of the first catheter. The phrase “substantially straightened” may refer to a configuration of the first catheter in which the entire length of the first catheter, including bending portion(s) thereof, may be straight and unbent. In some embodiments, the bending portion of the second catheter can remain substantially straightened while the bending portion of the first catheter is bent. For example, bending portion 7225 of the guide catheter 7220 (i.e., the exemplary second catheter) may be positioned distal to or outside of the outer sheath 7210 (i.e. the exemplary first catheter).
As described above, the first and second catheters may be flexible, and the first and second steering mechanisms may be configured to selectively bend the first and second catheters respectively at a range of angles as desired. In some exemplary embodiments, the first catheter and the second catheter may each be configured to bend (e.g., within the first and second steering planes) out of the straight configurations thereof by an angle greater than 90°. In some exemplary embodiments, the first catheter and the second catheter may each be configured to bend (e.g., within the first and second steering planes) out of the straight configurations thereof by an angle no greater than 120° (that is, an angle equal to or less than 120°). In some embodiments, one or more of the first catheter and second catheter may be configured for unidirectional bending out of the straight configurations thereof. Additionally, or alternatively, one or more of the first catheter and second catheter may be configured for bidirectional bending out of the straight configurations thereof.
In some embodiments, an exemplary prosthetic valve delivery system may include a third catheter coaxially arranged within the second catheter. The third catheter may be situated at least partially within the second catheter and may be configured for axial movement relative to the first catheter and the second catheter. In some embodiments, the third catheter may be the inner-most catheter of the prosthetic valve delivery system. For example, one or more tubular structures may be situated between the second catheter and the third catheter. Alternatively, one or more tubular structures may be situated at least partially within the third catheter.
In some embodiments, the third catheter may include a third steering mechanism configured to bend the third catheter within a third steering plane, different from the first and second steering planes. In some embodiments, the third steering mechanism may be actuated by a user to effect bending of the third catheter within the third steering plane. For example, in
In some embodiments of the prosthetic valve delivery system, at least a portion of the capsule may be configured for longitudinal movement relative to the first catheter, second catheter, and third catheter. The term “longitudinal movement” may refer to axial translation of the portion of the capsule relative to the first, second, and third catheters and may constitute movement away from and/or towards the first, second, and third catheters. For example, the prosthetic valve delivery system may include a capsule shaft, which may be connected to a proximal capsule portion of the delivery capsule and configured for axial movement relative to the first, second, and third catheters. Accordingly, the proximal capsule portion may be configured for axial movement relative to the first, second, and third catheters via movement of the capsule shaft relative to the first, second, and third catheters. In some embodiments, the capsule shaft may be included within the telescoping catheter assembly and may be situated within the second catheter. Additionally, or alternatively, the third catheter may, in turn, be situated within the capsule shaft. For example, as illustrated in
In an exemplary prosthetic valve delivery system, the first catheter, the second catheter, and the third catheter may all be configured for relative longitudinal movement. Accordingly, each catheter may be configured to move independently in a proximal and/or distal direction, regardless of the movement or stationary nature of the other catheters, which may allow for independent control of the longitudinal position of each catheter. For example, the second catheter may be configured to move longitudinally while the first and third catheter remain in their respective longitudinal position with respect to the second catheter. That is, the second catheter may translate proximally or distally while the first catheter and the third catheter remain in their respective longitudinal positions. For example,
As described above, the first steering mechanism and the second steering mechanism can be configured to cause the first catheter and second catheter, respectively, to bend. In some embodiments, the first and second steering mechanisms may be configured to actuate bending of the first and second catheters, respectively, within desired first and second steering planes to allow correct placement of the prosthetic valve at the implantation site.
In some embodiments, the first catheter and features nested therein (including the second catheter and third catheter) may be delivered to the heart and into the left atrium over a guide wire. For example, once the distal end of the outer sheath 7210 (i.e. the exemplary first catheter) is situated within the left atrium 9010, the first steering mechanism 7122 may be actuated to bend the outer sheath 7210 within the first steering plane 7212 until the capsule 7300 is positioned directly upstream of the native mitral valve 9030. The guide catheter 7220 (i.e., the exemplary second catheter) may be bent within the second steering plane 7222 by the second steering mechanism 7142, as well as axially extended from and/or retracted into the outer sheath 7210 (if needed), until the capsule 7300 is co-linearly aligned with the native mitral valve 9030 (as illustrated in
In some embodiments of the prosthetic valve delivery system, the first catheter and the second catheter may be configured to bend the third catheter by an angle greater than 180°, relative to a straight configuration of the third catheter. For example, the first and second catheters can each be bent by more than 90° in the same plane, resulting in bending of the third catheter by more than 180° due to the fact that the third catheter may be bent by bending of the first catheter and of the second catheter. An example of this is illustrated in
In some embodiments of the prosthetic valve delivery system, an exemplary capsule may include multiple portions, including a distal capsule portion and a proximal capsule portion. The distal capsule portion may be positioned distal to the proximal capsule portion. The distal and proximal capsule portions may each be hollow structures and may include at least one opening therein. In some embodiments, the distal and proximal capsule sections may be drawn together to form the receptacle in which the prosthetic valve may be held. For example, the openings of the distal and proximal capsule portions may be drawn together, thus forming an enclosed and optionally airtight capsule. The distal capsule portion and the proximal capsule portion may be configured for movement in opposing directions, such as opposing longitudinal directions. For example, the opposing directions may be distally and proximally. In such an example, one of the distal and proximal capsule portions can be configured to move proximally while the other capsule portion can be configured to move distally. In some embodiments, the capsule portions may be configured such that their relative movement may selectively release a prosthetic valve enclosed therein.
In some embodiments, the distal capsule portion may be configured to retain a ventricular portion of the prosthetic valve therein, and the proximal capsule portion may be configured to retain an atrial portion of the prosthetic valve therein. The “ventricular portion” of the prosthetic valve may refer to a portion of the prosthetic valve that includes the end of the prosthetic valve configured to be situated at a location within the ventricle that is furthest from the atrium when the prosthetic valve is implanted. Similarly, the “atrial portion” of the prosthetic valve may refer to a portion of the prosthetic valve that includes the end of the prosthetic valve configured to be situated at a location within the atrium that is furthest from the ventricle when the prosthetic valve is implanted. In some embodiments, the distal capsule portion may be configured such that longitudinal movement thereof may release the ventricular portion of the prosthetic valve from retention therein. Additionally, or alternatively, the proximal capsule portion may be configured such that longitudinal movement thereof may release the atrial portion of the prosthetic valve from retention therein. In reference to exemplary prosthetic valve 6000, depicted, for example, in
In some embodiments, an axial length of the ventricular capsule portion may be at least twice as long as an axial length of the atrial capsule portion. In some embodiments, the axial length of the ventricular capsule portion may include the axial length of a flexible protective feature secured to the distal end of the ventricular capsule portion (such as nose cone 7360 illustrated in
In some embodiments, the exemplary distal capsule portion may be configured to retain an annular valve body of the prosthetic valve therein. The annular valve body may be a ring-shaped structure of the prosthetic valve having at least one opening therein. The at least one opening may extend longitudinally along the entire length of the annular valve body. For example, annular valve body 2020 illustrated in
In some embodiments, the distal capsule portion may additionally or alternatively be configured to retain a plurality of ventricular anchoring legs of the prosthetic valve therein. In some embodiments, the ventricular anchoring legs may be configured to engage ventricular tissue of a native atrioventricular valve (e.g., a mitral valve) to anchor the prosthetic valve therein. For example,
In some embodiments, the proximal capsule portion may be configured to retain a plurality of atrial anchoring arms of the prosthetic valve therein. Exemplary atrial anchoring arms may be configured to engage atrial tissue of a native atrioventricular valve (e.g., a mitral valve) to anchor the prosthetic valve therein. For example,
An example of such a configuration is depicted in
In some embodiments, a capsule of the exemplary prosthetic valve delivery system may include a valve anchor configured to secure the prosthetic valve during movement of one or more of the distal capsule portion and the proximal capsule portion. The valve anchor may be located within the capsule (e.g., within the distal capsule portion) and may selectively prevent longitudinal movement of the prosthetic valve relative thereto. In some embodiments, the valve anchor may directly engage the prosthetic valve to secure the valve against longitudinal movement. In some embodiments, the valve anchor may be positioned inside of the capsule, and in other embodiments, the valve anchor may be positioned outside of the capsule. The valve anchor may have one or more recesses that are configured to receive one or more ventricular end delivery posts of the prosthetic valve. The one or more recesses may selectively prevent longitudinal movement of the prosthetic valve. The recesses may secure the prosthetic valve to the valve anchor until the annular body of the prosthetic valve expands radially outward, thus releasing the prosthetic valve from the valve anchor. The recesses in the valve anchor may include slots, holes, hooks, openings, or any suitable receptacle configured to receive at least a portion of the prosthetic valve, such as one or more ventricular end delivery posts of the prosthetic valve. The ventricular end delivery posts may be positioned on or near the ventricular end of the prosthetic valve and may take a number of forms and shapes including D-shaped, tapered, threaded, barbed, keyed, among others, so as to secure the posts to the recesses in the valve anchor.
An exemplary prosthetic valve delivery system may include a first capsule actuator configured to effect longitudinal movement of the distal capsule portion relative to the valve anchor. For example, in exemplary prosthetic valve delivery system 7000, distal capsule portion knob 7170 may be configured to effect longitudinal movement of distal capsule portion 7340 relative to the valve anchor disc 8200 (i.e., the exemplary valve anchor), and may thus be considered a first capsule actuator. The first capsule actuator may be configured to effect proximal and/or distal movement of the distal capsule portion relative to the valve anchor. In some embodiments, the first capsule actuator may be incorporated within a control handle assembly, which may be operated by a user to control different components of the prosthetic valve delivery system. Alternatively, the first capsule actuator may be incorporated within an independent control system. The first capsule actuator may include any appropriate mechanism, examples of which include, but are not limited to, a rotatable knob, a wheel, a handle, a lever, a joystick, a touchpad, and combinations thereof, among other mechanisms suitable for effecting longitudinal movement of the distal capsule portion relative to the valve anchor. In some embodiments, the first capsule actuator may be configured to effect distal movement of the distal capsule portion so as to release the ventricular anchoring legs and the annular valve body therefrom.
In some embodiments, the exemplary first capsule actuator may be configured to move the distal capsule portion to a first position in which a portion (e.g. the ventricular anchoring legs) of the prosthetic valve may be released from the capsule while the prosthetic valve remains secured relative to the capsule. Additionally, or alternatively, the first capsule actuator may be configured to move the distal capsule portion to a second position in which the prosthetic valve may be released from the capsule. In some embodiments, the first position may be a position of the distal capsule portion in which at least a portion of the ventricular anchoring legs extend out of the distal capsule portion, but in which at least a portion of the annular valve body remains radially constrained within the distal capsule portion and secured against longitudinal movement relative to at least a portion of the capsule. For example, the annular valve body may remain engaged with the valve anchor while the distal capsule portion is located at the first position thereof. In some embodiments, a portion of each ventricular anchoring leg may extend out of the distal capsule portion when the distal capsule portion is situated at the first position. Alternatively, the entirety of each ventricular anchoring leg may extend out of the distal capsule portion when the distal capsule portion is situated at the first position. The first capsule actuator may move the distal capsule portion by twisting, translation, actuation, or other mechanisms so that the distal capsule portion can be moved to the first position thereof. An exemplary first position of the distal capsule portion is illustrated in
In some embodiments, the second position of the distal capsule portion may be a position in which the entirety of the annular valve body may be removed from the distal capsule portion. At this position, the annular valve body may be configured to radially expand, so it is no longer constrained by the distal capsule portion. As a result, in some embodiments, the annular valve body may be freed from engagement with the valve anchor and the prosthetic valve may be configured for longitudinal movement relative to the valve anchor. An exemplary second position of the distal capsule portion is illustrated in
In some embodiments, the atrial anchoring arms may be retained within the proximal capsule portion and may be released when the proximal capsule portion is translated proximally by a second capsule actuator (discussed further below), creating a gap between the distal capsule portion and the proximal capsule portion that allows the anchoring arms to be released from the proximal capsule portion. The proximal capsule portion may be configured to translate independently of the distal capsule portion. For example, the proximal capsule portion may be moved longitudinally until the atrial anchoring arms are released, while the ventricular anchoring legs and the annular valve body may remain in a radially-contracted configuration within the distal capsule portion.
The prosthetic valve delivery system may additionally or alternatively include a second capsule actuator configured to effect longitudinal movement of the proximal capsule portion relative to the valve anchor. For example, in exemplary prosthetic valve delivery system 7000, proximal capsule portion slider 7162 may be configured to effect longitudinal movement of the proximal capsule portion 7320 relative to the valve anchor disc 8200 (i.e., the exemplary valve anchor), and may thus be considered a second capsule actuator. The second capsule actuator may be configured to effect proximal and distal movement of the proximal capsule portion relative to the valve anchor and the distal capsule portion. In some embodiments, the second capsule actuator may be incorporated within a control handle assembly, which may be operated by a user to control different components of the prosthetic valve delivery system. Alternatively, the second capsule actuator may be incorporated within an independent control system. Although the second capsule actuator is depicted as a slider 7162 in the example depicted in
An exemplary prosthetic valve delivery system may include a handle configured to enable rotation of the first catheter and the second catheter. The handle may include any manual control mechanism, including a knob, lever, rotatable cuff, slider, or any other suitable structure capable of causing rotation of the first catheter and the second catheter. The handle may be incorporated within an exemplary control handle assembly, which may be operated by a user to control different components of the prosthetic valve delivery system. In some embodiments, the handle may be mechanically connected to the first catheter and the second catheter via one or more suitable mechanical connections, such as welding, adhesive, interference fit, over molding, threading, or barbs, such that actuation (e.g. rotation) of the handle may translate to rotational movement of the first catheter and second catheter. In some embodiments, the connection between the handle and the first catheter and the second catheter may be replaceable or disposable, so that after each use of the prosthetic valve delivery system, the first and second catheters can be replaced. In some embodiments, the handle may be incorporated within an independent control system.
An exemplary prosthetic valve delivery system may include a first catheter actuator configured to effect bending of the first catheter within the first steering plane. In some embodiments, the first catheter actuator may be configured to effect longitudinal movement of the first catheter. Additionally, or alternatively, the prosthetic valve delivery system may include a second catheter actuator configured to effect longitudinal movement of the second catheter and bending of the second catheter within the second steering plane. The term “actuator” can include any manual control mechanism, including a knob, lever, rotatable cuff, slider, or any other structure capable of causing longitudinal movement and bending. The first catheter actuator and second catheter actuator may be any manual control mechanism, and the first catheter actuator and second catheter actuator may be different manual control mechanisms. The first catheter actuator and the second catheter actuator may be connected to or associated with one or more pull wires connected to the first catheter and the second catheter. Accordingly, the first catheter actuator and the second catheter actuator may be connected to or integral with the first steering mechanism and the second steering mechanism that may control the one or more pull wires. In some embodiments, the first catheter and the second catheter can each have at least one pull wire connected thereto at a position along the length of the first catheter and the second catheter. For example, a pull wire may be connected directly to or near the distal end of the first catheter and a pull wire may be connected directly to or near the distal end of the second catheter. Additionally, or alternatively, the first catheter and the second catheter may have additional pull wires connected at various proximal locations in each catheter. The first catheter actuator and the second catheter actuator may provide control of the first steering mechanism and the second steering mechanism, which may pull on the one or more pull wires to effect bending of the first catheter and the second catheter. In some embodiments, the first catheter actuator and the second catheter actuator may additionally, or alternatively, include other mechanisms suitable for effecting catheter bending. In some embodiments, the first catheter actuator and second catheter actuator may be incorporated within an exemplary control handle assembly (e.g., prosthetic valve delivery system 7000), which may be operated by a user to control different components of the prosthetic valve delivery system. Alternatively, the first catheter actuator and second catheter actuator may each be incorporated within an independent control handle assembly.
Outer sheath steering knob 7122 may be connected to or integral with the first catheter actuator 7120. Outer sheath steering knob 7122 is shown as a rotatable knob, but may alternatively be a wheel, a handle, a joystick, a touchpad, and combinations thereof, among other steering mechanisms capable of effecting bending of the first catheter within the first steering plane. For example, outer sheath steering knob 7122 may be connected to a pull wire connected to the first catheter to effect bending thereof.
In some embodiments, the second catheter actuator 7140 may be a handle extending from control handle assembly 7100 that may be mechanically connected to the second catheter to effect longitudinal movement of the second catheter and bending of the second catheter within the second steering plane. The second catheter actuator 7140 may be configured to translate proximally and distally with respect to the remainder of the control handle assembly 7100, and the proximal or distal translation of the second catheter actuator 7140 may control the longitudinal movement of the guide catheter 7220 (i.e., the exemplary second catheter). Guide catheter steering knob 7142 may be connected to or integral with the second catheter actuator 7140. Guide catheter steering knob 7142 is shown as a rotatable knob, but may alternatively be a wheel, a handle, a joystick, a touchpad, and combinations thereof, among other steering mechanisms capable of effecting bending of the second catheter within the second steering plane. For example, guide catheter steering knob 7142 may be connected to a pull wire connected to the second catheter to effect bending thereof. Guide catheter steering knob 7142 and second catheter actuator 7140 may be operated simultaneously or independently, that is, the second catheter can move longitudinally and bend at the same time or the second catheter can operate independently to move longitudinally or to bend.
In some embodiments, the first catheter actuator and second catheter actuator may be configured for relative longitudinal movement. In some embodiments, the first and second catheter actuators may both be configured for independent longitudinal movement. In alternative embodiments, one actuator may be secured against longitudinal movement (e.g., due to locking of the one actuator to an exemplary control handle assembly), while the other actuator may be configured to move longitudinally. Relative longitudinal movement between the first and second catheter actuators may effect relative longitudinal movement between the first and second catheters. In some embodiments, the first catheter actuator and the second catheter actuator may be connected to, or otherwise incorporated within, a control handle assembly and may be situated at different longitudinal positions within the control handle assembly. In some embodiments, the control handle assembly may be configured to guide the longitudinal movement of the first catheter actuator and/or the second catheter actuator. For example, one or both of the first catheter actuator and the second catheter actuator may be configured to move longitudinally on a slider, a rod, a rail, a track, or any suitable guide structure on the control handle assembly. Accordingly, the first catheter actuator and the second catheter actuator may be configured for relative longitudinal movement either towards or away from each other.
In some embodiments, the prosthetic valve delivery system may include a catheter lock configured to prevent relative longitudinal movement of the first catheter and the second catheter. In some embodiments, the catheter lock may secure the first catheter and the second catheter against any longitudinal movement, such as by locking one or both of the first and second catheters to an exemplary control handle assembly. In some alternative embodiments, the catheter lock may secure one or both of exemplary first and second catheter actuators (to which the first and second catheters, respectively, may be secured) to the exemplary control handle assembly. In further alternative embodiments, the catheter lock may secure the first and second catheters together such that they move longitudinally in tandem. The catheter lock may include any suitable locking mechanism, including a clip or friction fit, a threaded lock, a toothed gear lock, a snap fit lock, a spring-actuated lock, or any other structure capable of preventing relative longitudinal movement between the first catheter and the second catheter and, in some embodiments, securing one or both of the first and second catheters against any longitudinal movement. In some embodiments, the catheter lock may mechanically connect to the first catheter and the second catheter, or to elements secured thereto, and can secure the two catheters together so that relative movement cannot occur between the two catheters when the catheter lock is engaged.
For example, control handle assembly 7100 depicted in
In some embodiments, the first catheter and second catheter may be configured to advance the capsule through vasculature and across a fossa to position the prosthetic valve within a heart chamber. The first catheter and second catheter may be configured to approach the heart transfemorally, transapically, transatrially, or transseptally. Specifically, as in an example discussed above, the first catheter can cross the fossa ovalis and enter the left atrium of the patient's heart. In this example, the first steering plane may align with the fossa ovalis to ensure passage of the first catheter through the fossa ovalis. Once positioned in the left atrium, the second catheter can translate from the distal end of the first catheter. The second catheter steering mechanism can align the second catheter steering plane with the native mitral valve plane such that the second catheter can position the capsule at a position co-linear with the native mitral plane. The “native mitral plane” refers to the plane corresponding to the passageway through the native mitral valve of the patient.
The foregoing description has been presented for purposes of illustration. It is not exhaustive and is not limited to precise forms or embodiments disclosed. Modifications and adaptations of the embodiments will be apparent from consideration of the specification and practice of the disclosed embodiments. For example, while certain components have been described as being coupled to one another, such components may be integrated with one another or distributed in any suitable fashion.
Moreover, while illustrative embodiments have been described herein, the scope includes any and all embodiments having equivalent elements, modifications, omissions, combinations (e.g., of aspects across various embodiments), adaptations and/or alterations based on the present disclosure. The elements in the claims are to be interpreted broadly based on the language employed in the claims and not limited to examples described in the present specification or during the prosecution of the application, which examples are to be construed as nonexclusive. Further, the steps of the disclosed methods can be modified in any manner, including reordering steps and/or inserting or deleting steps.
The features and advantages of the disclosure are apparent from the detailed specification, and thus, it is intended that the appended claims cover all systems and methods falling within the true spirit and scope of the disclosure. As used herein, the indefinite articles “a” and “an” mean “one or more.” Similarly, the use of a plural term does not necessarily denote a plurality unless it is unambiguous in the given context. Words such as “and” or “or” mean “and/or” unless specifically directed otherwise. Further, since numerous modifications and variations will readily occur from studying the present disclosure, it is not desired to limit the disclosure to the exact construction and operation illustrated and described, and accordingly, all suitable modifications and equivalents may be resorted to, falling within the scope of the disclosure.
Other embodiments will be apparent from consideration of the specification and practice of the embodiments disclosed herein. It is intended that the specification and examples be considered as example only, with a true scope and spirit of the disclosed embodiments being indicated by the following claims.
This application claims priority from U.S. Provisional Patent Application No. 62/560,384, filed Sep. 19, 2017, which is hereby incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3874388 | King et al. | Apr 1975 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4340091 | Skelton et al. | Jul 1982 | A |
4972494 | White et al. | Nov 1990 | A |
5201757 | Heyn et al. | Apr 1993 | A |
5713948 | Uflacker | Feb 1998 | A |
5716417 | Girard et al. | Feb 1998 | A |
5741297 | Simon | Apr 1998 | A |
5776140 | Cottone | Jul 1998 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
5961549 | Nguyen et al. | Oct 1999 | A |
6010530 | Goicoechea | Jan 2000 | A |
6126686 | Badylak et al. | Oct 2000 | A |
6165183 | Kuehn et al. | Dec 2000 | A |
6254609 | Vrba et al. | Jul 2001 | B1 |
6312465 | Griffin et al. | Nov 2001 | B1 |
6346074 | Roth | Feb 2002 | B1 |
6402780 | Williamson, IV et al. | Jun 2002 | B2 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6669724 | Park et al. | Dec 2003 | B2 |
6733525 | Yang et al. | May 2004 | B2 |
6752813 | Goldfarb et al. | Jun 2004 | B2 |
6755857 | Peterson et al. | Jun 2004 | B2 |
6926715 | Hauck et al. | Aug 2005 | B1 |
6939370 | Hartley et al. | Sep 2005 | B2 |
7074236 | Rabkin et al. | Jul 2006 | B2 |
7201772 | Schwammenthal et al. | Apr 2007 | B2 |
7226467 | Lucatero et al. | Jun 2007 | B2 |
7261686 | Couvillon, Jr. | Aug 2007 | B2 |
7288097 | Séguin | Oct 2007 | B2 |
7442204 | Schwammenthal et al. | Oct 2008 | B2 |
7556632 | Zadno | Jul 2009 | B2 |
7563267 | Goldfarb et al. | Jul 2009 | B2 |
7563273 | Goldfarb et al. | Jul 2009 | B2 |
7608091 | Goldfarb et al. | Oct 2009 | B2 |
7635329 | Goldfarb et al. | Dec 2009 | B2 |
7655015 | Goldfarb et al. | Feb 2010 | B2 |
7736388 | Goldfarb et al. | Jun 2010 | B2 |
7753949 | Lamphere et al. | Jul 2010 | B2 |
7811296 | Goldfarb et al. | Oct 2010 | B2 |
7837727 | Goetz et al. | Nov 2010 | B2 |
7959672 | Salahieh et al. | Jun 2011 | B2 |
8052592 | Goldfarb et al. | Nov 2011 | B2 |
8057493 | Goldfarb et al. | Nov 2011 | B2 |
8070802 | Lamphere et al. | Dec 2011 | B2 |
D652927 | Braido et al. | Jan 2012 | S |
D653341 | Braido et al. | Jan 2012 | S |
8109996 | Stacchino et al. | Feb 2012 | B2 |
D660433 | Braido et al. | May 2012 | S |
D660967 | Braido et al. | May 2012 | S |
8216256 | Raschdorf, Jr. et al. | Jul 2012 | B2 |
8313525 | Tuval et al. | Nov 2012 | B2 |
8403983 | Quadri et al. | Mar 2013 | B2 |
8414644 | Quadri et al. | Apr 2013 | B2 |
8449599 | Chau et al. | May 2013 | B2 |
8568475 | Nguyen et al. | Oct 2013 | B2 |
8582672 | Bonhoeffer et al. | Oct 2013 | B2 |
8579964 | Lane et al. | Nov 2013 | B2 |
8585755 | Chau et al. | Nov 2013 | B2 |
8628571 | Hacohen et al. | Jan 2014 | B1 |
8652203 | Quadri et al. | Feb 2014 | B2 |
8657872 | Seguin | Feb 2014 | B2 |
8728155 | Montorfano et al. | May 2014 | B2 |
8747460 | Tuval et al. | Jun 2014 | B2 |
8784481 | Alkhatib et al. | Jul 2014 | B2 |
8852272 | Gross et al. | Oct 2014 | B2 |
8870948 | Erzberger et al. | Oct 2014 | B1 |
8870950 | Hacohen | Oct 2014 | B2 |
8961595 | Alkhatib | Feb 2015 | B2 |
8986375 | Garde et al. | Mar 2015 | B2 |
8992604 | Gross et al. | Mar 2015 | B2 |
8998982 | Richter et al. | Apr 2015 | B2 |
9017399 | Gross et al. | Apr 2015 | B2 |
D730520 | Braido et al. | May 2015 | S |
D730521 | Braido et al. | May 2015 | S |
9023100 | Quadri et al. | May 2015 | B2 |
D732666 | Nguyen et al. | Jun 2015 | S |
9050188 | Schweich, Jr. et al. | Jun 2015 | B2 |
9060858 | Thornton et al. | Jun 2015 | B2 |
9072603 | Tuval et al. | Jul 2015 | B2 |
9095434 | Rowe | Aug 2015 | B2 |
9119719 | Zipory et al. | Sep 2015 | B2 |
9125740 | Morriss et al. | Sep 2015 | B2 |
9132009 | Hacohen et al. | Sep 2015 | B2 |
9173659 | Bodewadt et al. | Nov 2015 | B2 |
9180009 | Majkrzak et al. | Nov 2015 | B2 |
9232995 | Kovalsky et al. | Jan 2016 | B2 |
9241790 | Lane et al. | Jan 2016 | B2 |
9241791 | Braido et al. | Jan 2016 | B2 |
9241792 | Benichou et al. | Jan 2016 | B2 |
9248014 | Lane et al. | Feb 2016 | B2 |
9277994 | Miller et al. | Mar 2016 | B2 |
9295551 | Straubinger et al. | Mar 2016 | B2 |
9295552 | McLean et al. | Mar 2016 | B2 |
9320591 | Bolduc | Apr 2016 | B2 |
D755384 | Pesce et al. | May 2016 | S |
9345573 | Nyuli et al. | May 2016 | B2 |
9358107 | Nguyen et al. | Jun 2016 | B2 |
9387078 | Gross et al. | Jul 2016 | B2 |
9393110 | Levi et al. | Jul 2016 | B2 |
9439757 | Wallace et al. | Sep 2016 | B2 |
9445893 | Vaturi | Sep 2016 | B2 |
9463102 | Kelly | Oct 2016 | B2 |
9492273 | Wallace et al. | Nov 2016 | B2 |
9532870 | Cooper et al. | Jan 2017 | B2 |
9554897 | Lane et al. | Jan 2017 | B2 |
9554899 | Granada et al. | Jan 2017 | B2 |
9561103 | Granada et al. | Feb 2017 | B2 |
9566152 | Schweich, Jr. et al. | Feb 2017 | B2 |
9572665 | Lane et al. | Feb 2017 | B2 |
9597182 | Straubinger et al. | Mar 2017 | B2 |
9629716 | Seguin | Apr 2017 | B2 |
9662203 | Sheahan et al. | May 2017 | B2 |
9681952 | Hacohen et al. | Jun 2017 | B2 |
9717591 | Chau et al. | Aug 2017 | B2 |
9763657 | Hacohen et al. | Sep 2017 | B2 |
9770256 | Cohen et al. | Sep 2017 | B2 |
D800908 | Hariton et al. | Oct 2017 | S |
9788941 | Hacohen | Oct 2017 | B2 |
9895226 | Harari et al. | Feb 2018 | B1 |
9974651 | Hariton et al. | May 2018 | B2 |
10010414 | Cooper et al. | Jul 2018 | B2 |
10076415 | Metchik et al. | Sep 2018 | B1 |
10105222 | Metchik et al. | Oct 2018 | B1 |
10111751 | Metchik et al. | Oct 2018 | B1 |
10123873 | Metchik et al. | Nov 2018 | B1 |
10130475 | Metchik et al. | Nov 2018 | B1 |
10136993 | Metchik et al. | Nov 2018 | B1 |
10143552 | Wallace et al. | Dec 2018 | B2 |
10149761 | Granada et al. | Dec 2018 | B2 |
10154906 | Granada et al. | Dec 2018 | B2 |
10159570 | Metchik et al. | Dec 2018 | B1 |
10182908 | Tubishevitz et al. | Jan 2019 | B2 |
10226341 | Gross et al. | Mar 2019 | B2 |
10231837 | Metchik et al. | Mar 2019 | B1 |
10238493 | Metchik et al. | Mar 2019 | B1 |
10245143 | Gross et al. | Apr 2019 | B2 |
10245144 | Metchik et al. | Apr 2019 | B1 |
10299927 | McLean et al. | May 2019 | B2 |
10321995 | Christianson et al. | Jun 2019 | B1 |
10322020 | Lam et al. | Jun 2019 | B2 |
10327895 | Lozonschi et al. | Jun 2019 | B2 |
10335278 | McLean et al. | Jul 2019 | B2 |
10357360 | Hariton et al. | Jul 2019 | B2 |
10376361 | Gross et al. | Aug 2019 | B2 |
10390952 | Hariton et al. | Aug 2019 | B2 |
10426610 | Hariton et al. | Oct 2019 | B2 |
10463487 | Hariton et al. | Nov 2019 | B2 |
10463488 | Hariton et al. | Nov 2019 | B2 |
10507105 | Hariton et al. | Dec 2019 | B2 |
10507108 | Delgado et al. | Dec 2019 | B2 |
10507109 | Metchik et al. | Dec 2019 | B2 |
10512456 | Hacohen et al. | Dec 2019 | B2 |
10517719 | Miller et al. | Dec 2019 | B2 |
10524792 | Hernandez et al. | Jan 2020 | B2 |
10524903 | Hariton et al. | Jan 2020 | B2 |
10531872 | Hacohen et al. | Jan 2020 | B2 |
10548731 | Lashinski et al. | Feb 2020 | B2 |
10575948 | Iamberger et al. | Mar 2020 | B2 |
10595992 | Chambers | Mar 2020 | B2 |
10595997 | Metchik et al. | Mar 2020 | B2 |
10610358 | Vidlund et al. | Apr 2020 | B2 |
10646342 | Marr et al. | May 2020 | B1 |
10667908 | Hariton et al. | Jun 2020 | B2 |
10682227 | Hariton et al. | Jun 2020 | B2 |
10695177 | Hariton et al. | Jun 2020 | B2 |
10702385 | Hacohen | Jul 2020 | B2 |
10722360 | Hariton et al. | Jul 2020 | B2 |
10758342 | Chau et al. | Sep 2020 | B2 |
10758344 | Hariton et al. | Sep 2020 | B2 |
10799345 | Hariton et al. | Oct 2020 | B2 |
10813760 | Metchik et al. | Oct 2020 | B2 |
10820998 | Marr et al. | Nov 2020 | B2 |
10842627 | Delgado et al. | Nov 2020 | B2 |
10849748 | Hariton et al. | Dec 2020 | B2 |
10856972 | Hariton et al. | Dec 2020 | B2 |
10856975 | Hariton et al. | Dec 2020 | B2 |
10856978 | Straubinger et al. | Dec 2020 | B2 |
10864078 | Hariton et al. | Dec 2020 | B2 |
10874514 | Dixon et al. | Dec 2020 | B2 |
10881511 | Hariton et al. | Jan 2021 | B2 |
10888422 | Hariton et al. | Jan 2021 | B2 |
10888644 | Ratz et al. | Jan 2021 | B2 |
10905548 | Hariton et al. | Feb 2021 | B2 |
10905549 | Hariton et al. | Feb 2021 | B2 |
10905552 | Dixon et al. | Feb 2021 | B2 |
10905554 | Cao | Feb 2021 | B2 |
10918483 | Metchik et al. | Feb 2021 | B2 |
10925595 | Hacohen et al. | Feb 2021 | B2 |
10945844 | McCann et al. | Mar 2021 | B2 |
10973636 | Hariton et al. | Apr 2021 | B2 |
10993809 | McCann et al. | May 2021 | B2 |
11083582 | McCann et al. | Aug 2021 | B2 |
11147672 | McCann et al. | Oct 2021 | B2 |
20010005787 | Oz et al. | Jun 2001 | A1 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20020013571 | Goldfarb et al. | Jan 2002 | A1 |
20020032481 | Gabbay | Mar 2002 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030074059 | Nguyen et al. | Apr 2003 | A1 |
20040030382 | St. Goar et al. | Feb 2004 | A1 |
20040186558 | Pavcnik et al. | Sep 2004 | A1 |
20040210304 | Seguin et al. | Oct 2004 | A1 |
20040236354 | Seguin | Nov 2004 | A1 |
20040249433 | Freitag | Dec 2004 | A1 |
20050027348 | Case et al. | Feb 2005 | A1 |
20050080474 | Andreas et al. | Apr 2005 | A1 |
20050085900 | Case et al. | Apr 2005 | A1 |
20050137681 | Shoemaker et al. | Jun 2005 | A1 |
20050137691 | Salahieh et al. | Jun 2005 | A1 |
20050137692 | Haug et al. | Jun 2005 | A1 |
20050137697 | Salahieh et al. | Jun 2005 | A1 |
20050203618 | Sharkawy et al. | Sep 2005 | A1 |
20050240200 | Bergheim | Oct 2005 | A1 |
20050256566 | Gabbay | Nov 2005 | A1 |
20060004469 | Sokel | Jan 2006 | A1 |
20060020275 | Goldfarb et al. | Jan 2006 | A1 |
20060020327 | Lashinski et al. | Jan 2006 | A1 |
20060030863 | Fields et al. | Feb 2006 | A1 |
20060052867 | Revuelta et al. | Mar 2006 | A1 |
20060184203 | Martin et al. | Aug 2006 | A1 |
20060195183 | Navia et al. | Aug 2006 | A1 |
20060216404 | Seyler et al. | Sep 2006 | A1 |
20060229708 | Powell et al. | Oct 2006 | A1 |
20060259137 | Artof et al. | Nov 2006 | A1 |
20060282150 | Olson et al. | Dec 2006 | A1 |
20070016286 | Herrmann et al. | Jan 2007 | A1 |
20070038293 | St.Goar et al. | Feb 2007 | A1 |
20070056346 | Spenser et al. | Mar 2007 | A1 |
20070078510 | Ryan | Apr 2007 | A1 |
20070197858 | Goldfarb et al. | Aug 2007 | A1 |
20070198077 | Cully et al. | Aug 2007 | A1 |
20070213810 | Newhauser et al. | Sep 2007 | A1 |
20070219630 | Chu | Sep 2007 | A1 |
20070239273 | Allen | Oct 2007 | A1 |
20070244546 | Francis | Oct 2007 | A1 |
20080065011 | Marchand | Mar 2008 | A1 |
20080071361 | Tuval et al. | Mar 2008 | A1 |
20080071369 | Tuval et al. | Mar 2008 | A1 |
20080082166 | Styrc et al. | Apr 2008 | A1 |
20080132989 | Snow et al. | Jun 2008 | A1 |
20080147182 | Righini et al. | Jun 2008 | A1 |
20080200980 | Robin et al. | Aug 2008 | A1 |
20080208328 | Antocci et al. | Aug 2008 | A1 |
20080208332 | Lamphere et al. | Aug 2008 | A1 |
20080221672 | Lamphere et al. | Sep 2008 | A1 |
20090005863 | Goetz et al. | Jan 2009 | A1 |
20090125098 | Chuter | May 2009 | A1 |
20090157175 | Benichou | Jun 2009 | A1 |
20090259306 | Rowe | Oct 2009 | A1 |
20090281619 | Le et al. | Nov 2009 | A1 |
20100022823 | Goldfarb et al. | Jan 2010 | A1 |
20100023120 | Holecek et al. | Jan 2010 | A1 |
20100049313 | Alon et al. | Feb 2010 | A1 |
20100100167 | Bortlein et al. | Apr 2010 | A1 |
20100161036 | Pintor et al. | Jun 2010 | A1 |
20100256737 | Pollock et al. | Oct 2010 | A1 |
20100312333 | Navia et al. | Dec 2010 | A1 |
20100331971 | Keränen et al. | Dec 2010 | A1 |
20110004227 | Goldfarb et al. | Jan 2011 | A1 |
20110004299 | Navia et al. | Jan 2011 | A1 |
20110029072 | Gabbay | Feb 2011 | A1 |
20110066233 | Thornton et al. | Mar 2011 | A1 |
20110137397 | Chau et al. | Jun 2011 | A1 |
20110144742 | Madrid et al. | Jun 2011 | A1 |
20110208283 | Rust | Aug 2011 | A1 |
20110224785 | Hacohen | Sep 2011 | A1 |
20110245911 | Quill et al. | Oct 2011 | A1 |
20110264196 | Savage et al. | Oct 2011 | A1 |
20110282439 | Thill et al. | Nov 2011 | A1 |
20110306916 | Nitzan et al. | Dec 2011 | A1 |
20110307049 | Kao | Dec 2011 | A1 |
20110313515 | Quadri et al. | Dec 2011 | A1 |
20110319989 | Lane et al. | Dec 2011 | A1 |
20120016468 | Robin et al. | Jan 2012 | A1 |
20120022629 | Perera et al. | Jan 2012 | A1 |
20120022639 | Hacohen et al. | Jan 2012 | A1 |
20120059458 | Buchbinder | Mar 2012 | A1 |
20120065464 | Ellis et al. | Mar 2012 | A1 |
20120078237 | Wang et al. | Mar 2012 | A1 |
20120078353 | Quadri et al. | Mar 2012 | A1 |
20120089223 | Nguyen et al. | Apr 2012 | A1 |
20120101571 | Thambar et al. | Apr 2012 | A1 |
20120165930 | Gifford, III et al. | Jun 2012 | A1 |
20120296418 | Bonyuet et al. | Nov 2012 | A1 |
20120300063 | Majkrzak et al. | Nov 2012 | A1 |
20120310328 | Olson et al. | Dec 2012 | A1 |
20120323316 | Chau et al. | Dec 2012 | A1 |
20130018458 | Yohanan et al. | Jan 2013 | A1 |
20130046373 | Cartledge et al. | Feb 2013 | A1 |
20130066342 | Dell et al. | Mar 2013 | A1 |
20130144381 | Quadri et al. | Jun 2013 | A1 |
20130178930 | Straubinger et al. | Jul 2013 | A1 |
20130190861 | Chau et al. | Jul 2013 | A1 |
20130231735 | Deem | Sep 2013 | A1 |
20130253643 | Rolando et al. | Sep 2013 | A1 |
20130261738 | Clague et al. | Oct 2013 | A1 |
20130274870 | Lombardi et al. | Oct 2013 | A1 |
20130282059 | Ketai et al. | Oct 2013 | A1 |
20130289711 | Liddy et al. | Oct 2013 | A1 |
20130289740 | Liddy et al. | Oct 2013 | A1 |
20130304200 | McLean et al. | Nov 2013 | A1 |
20140000112 | Braido et al. | Jan 2014 | A1 |
20140018915 | Biadillah et al. | Jan 2014 | A1 |
20140067050 | Costello et al. | Mar 2014 | A1 |
20140142688 | Duffy et al. | May 2014 | A1 |
20140172077 | Bruchman et al. | Jun 2014 | A1 |
20140172082 | Bruchman et al. | Jun 2014 | A1 |
20140194981 | Menk et al. | Jul 2014 | A1 |
20140207231 | Hacohen et al. | Jul 2014 | A1 |
20140222136 | Geist et al. | Aug 2014 | A1 |
20140222142 | Kovalsky et al. | Aug 2014 | A1 |
20140236287 | Clague et al. | Aug 2014 | A1 |
20140236289 | Alkhatib | Aug 2014 | A1 |
20140249622 | Carmi et al. | Sep 2014 | A1 |
20140257467 | Lane et al. | Sep 2014 | A1 |
20140277409 | Bortlein et al. | Sep 2014 | A1 |
20140277411 | Bortlein et al. | Sep 2014 | A1 |
20140277418 | Miller | Sep 2014 | A1 |
20140277422 | Ratz et al. | Sep 2014 | A1 |
20140277427 | Ratz et al. | Sep 2014 | A1 |
20140296969 | Tegels et al. | Oct 2014 | A1 |
20140324164 | Gross et al. | Oct 2014 | A1 |
20140343670 | Bakis et al. | Nov 2014 | A1 |
20140358222 | Gorman, III et al. | Dec 2014 | A1 |
20140358224 | Tegels et al. | Dec 2014 | A1 |
20150018944 | O'Connell et al. | Jan 2015 | A1 |
20150032205 | Matheny | Jan 2015 | A1 |
20150142100 | Morriss et al. | May 2015 | A1 |
20150142103 | Vidlund | May 2015 | A1 |
20150157457 | Hacohen | Jun 2015 | A1 |
20150157458 | Thambar et al. | Jun 2015 | A1 |
20150173896 | Richter et al. | Jun 2015 | A1 |
20150173897 | Raanani et al. | Jun 2015 | A1 |
20150196390 | Ma et al. | Jul 2015 | A1 |
20150196393 | Vidlund et al. | Jul 2015 | A1 |
20150216661 | Hacohen et al. | Aug 2015 | A1 |
20150238313 | Spence et al. | Aug 2015 | A1 |
20150245934 | Lombardi | Sep 2015 | A1 |
20150250588 | Yang et al. | Sep 2015 | A1 |
20150272730 | Melnick et al. | Oct 2015 | A1 |
20150272734 | Sheps et al. | Oct 2015 | A1 |
20150320556 | Levi et al. | Nov 2015 | A1 |
20150327994 | Morriss et al. | Nov 2015 | A1 |
20150328000 | Ratz et al. | Nov 2015 | A1 |
20150335429 | Morriss et al. | Nov 2015 | A1 |
20150351903 | Morriss et al. | Dec 2015 | A1 |
20150351904 | Cooper et al. | Dec 2015 | A1 |
20150351906 | Hammer et al. | Dec 2015 | A1 |
20150359629 | Ganesan et al. | Dec 2015 | A1 |
20150359631 | Sheahan et al. | Dec 2015 | A1 |
20160030169 | Shahriari | Feb 2016 | A1 |
20160030171 | Quijano et al. | Feb 2016 | A1 |
20160089482 | Siegenthaler | Mar 2016 | A1 |
20160100939 | Amstrong et al. | Apr 2016 | A1 |
20160113765 | Ganesan et al. | Apr 2016 | A1 |
20160113766 | Ganesan et al. | Apr 2016 | A1 |
20160113768 | Ganesan et al. | Apr 2016 | A1 |
20160158497 | Tran et al. | Jun 2016 | A1 |
20160175095 | Dienno et al. | Jun 2016 | A1 |
20160184098 | Vaturi | Jun 2016 | A1 |
20160262885 | Sandstrom et al. | Sep 2016 | A1 |
20160270911 | Ganesan et al. | Sep 2016 | A1 |
20160310268 | Oba et al. | Oct 2016 | A1 |
20160317305 | Pelled et al. | Nov 2016 | A1 |
20160324633 | Gross et al. | Nov 2016 | A1 |
20160324635 | Vidlund et al. | Nov 2016 | A1 |
20160331525 | Straubinger et al. | Nov 2016 | A1 |
20160331526 | Schweich, Jr. et al. | Nov 2016 | A1 |
20160338706 | Rowe | Nov 2016 | A1 |
20160374801 | Jimenez et al. | Dec 2016 | A1 |
20160374802 | Levi et al. | Dec 2016 | A1 |
20170042678 | Ganesan et al. | Feb 2017 | A1 |
20170049435 | Sauer et al. | Feb 2017 | A1 |
20170056166 | Ratz et al. | Mar 2017 | A1 |
20170056171 | Cooper et al. | Mar 2017 | A1 |
20170065411 | Grundeman et al. | Mar 2017 | A1 |
20170128205 | Tamir | May 2017 | A1 |
20170135816 | Lashinski et al. | May 2017 | A1 |
20170189174 | Braido et al. | Jul 2017 | A1 |
20170209264 | Chau et al. | Jul 2017 | A1 |
20170224323 | Rowe et al. | Aug 2017 | A1 |
20170231757 | Gassier | Aug 2017 | A1 |
20170231759 | Geist et al. | Aug 2017 | A1 |
20170231766 | Hariton et al. | Aug 2017 | A1 |
20170239048 | Goldfarb et al. | Aug 2017 | A1 |
20170325948 | Wallace et al. | Nov 2017 | A1 |
20170333183 | Backus | Nov 2017 | A1 |
20170333187 | Hariton et al. | Nov 2017 | A1 |
20170367823 | Hariton et al. | Dec 2017 | A1 |
20180000580 | Wallace et al. | Jan 2018 | A1 |
20180021129 | Peterson et al. | Jan 2018 | A1 |
20180028215 | Cohen | Feb 2018 | A1 |
20180049873 | Manash et al. | Feb 2018 | A1 |
20180055630 | Patel et al. | Mar 2018 | A1 |
20180098850 | Rafiee et al. | Apr 2018 | A1 |
20180116843 | Schreck et al. | May 2018 | A1 |
20180125644 | Conklin | May 2018 | A1 |
20180153689 | Maimon et al. | Jun 2018 | A1 |
20180206983 | Noe et al. | Jul 2018 | A1 |
20180214263 | Rolando et al. | Aug 2018 | A1 |
20180250126 | O'Connor et al. | Sep 2018 | A1 |
20180250130 | Hariton et al. | Sep 2018 | A1 |
20180250147 | Syed | Sep 2018 | A1 |
20180256323 | Hariton et al. | Sep 2018 | A1 |
20180256325 | Hariton et al. | Sep 2018 | A1 |
20180271654 | Hariton et al. | Sep 2018 | A1 |
20180271655 | Hariton et al. | Sep 2018 | A1 |
20180289479 | Hariton et al. | Oct 2018 | A1 |
20180296336 | Cooper et al. | Oct 2018 | A1 |
20180338829 | Hariton et al. | Nov 2018 | A1 |
20180338830 | Hariton et al. | Nov 2018 | A1 |
20180338831 | Hariton et al. | Nov 2018 | A1 |
20180344457 | Gross et al. | Dec 2018 | A1 |
20180353294 | Calomeni et al. | Dec 2018 | A1 |
20180360457 | Ellis et al. | Dec 2018 | A1 |
20190015093 | Hacohen et al. | Jan 2019 | A1 |
20190053896 | Adamek-Bowers et al. | Feb 2019 | A1 |
20190060060 | Chau et al. | Feb 2019 | A1 |
20190060068 | Cope et al. | Feb 2019 | A1 |
20190060070 | Groothuis et al. | Feb 2019 | A1 |
20190069997 | Ratz et al. | Mar 2019 | A1 |
20190083242 | Hariton et al. | Mar 2019 | A1 |
20190083243 | Hariton et al. | Mar 2019 | A1 |
20190083246 | Hariton et al. | Mar 2019 | A1 |
20190083247 | Hariton et al. | Mar 2019 | A1 |
20190105153 | Barash et al. | Apr 2019 | A1 |
20190117391 | Humair | Apr 2019 | A1 |
20190175339 | Vidlund | Jun 2019 | A1 |
20190183639 | Moore | Jun 2019 | A1 |
20190192295 | Spence et al. | Jun 2019 | A1 |
20190328519 | Hariton et al. | Oct 2019 | A1 |
20190336280 | Naor et al. | Nov 2019 | A1 |
20190343627 | Hariton et al. | Nov 2019 | A1 |
20190350701 | Adamek-Bowers et al. | Nov 2019 | A1 |
20190365530 | Hoang et al. | Dec 2019 | A1 |
20190388218 | Vidlund et al. | Dec 2019 | A1 |
20190388220 | Vidlund et al. | Dec 2019 | A1 |
20190388223 | Hariton et al. | Dec 2019 | A1 |
20200000449 | Goldfarb et al. | Jan 2020 | A1 |
20200000579 | Manash et al. | Jan 2020 | A1 |
20200015964 | Noe et al. | Jan 2020 | A1 |
20200030098 | Delgado et al. | Jan 2020 | A1 |
20200046497 | Hariton et al. | Feb 2020 | A1 |
20200054335 | Hernandez et al. | Feb 2020 | A1 |
20200054451 | Hariton et al. | Feb 2020 | A1 |
20200060818 | Geist et al. | Feb 2020 | A1 |
20200069424 | Hariton et al. | Mar 2020 | A1 |
20200113677 | McCann et al. | Apr 2020 | A1 |
20200113689 | McCann et al. | Apr 2020 | A1 |
20200113692 | McCann et al. | Apr 2020 | A1 |
20200129294 | Hariton et al. | Apr 2020 | A1 |
20200138567 | Marr et al. | May 2020 | A1 |
20200146671 | Hacohen et al. | May 2020 | A1 |
20200163761 | Hariton et al. | May 2020 | A1 |
20200214832 | Metchik et al. | Jul 2020 | A1 |
20200237512 | McCann et al. | Jul 2020 | A1 |
20200246136 | Marr et al. | Aug 2020 | A1 |
20200246140 | Hariton et al. | Aug 2020 | A1 |
20200253600 | Darabian | Aug 2020 | A1 |
20200261094 | Goldfarb et al. | Aug 2020 | A1 |
20200315786 | Metchik et al. | Oct 2020 | A1 |
20200337842 | Metchik et al. | Oct 2020 | A1 |
20210085455 | Bateman et al. | Mar 2021 | A1 |
20210093449 | Hariton et al. | Apr 2021 | A1 |
20210113331 | Quadri et al. | Apr 2021 | A1 |
Number | Date | Country |
---|---|---|
2822801 | Aug 2006 | CA |
103974674 | Aug 2014 | CN |
1264582 | Dec 2002 | EP |
1637092 | Mar 2006 | EP |
2349124 | Oct 2018 | EP |
3583922 | Dec 2019 | EP |
3270825 | Apr 2020 | EP |
2485795 | Sep 2020 | EP |
WO 2003020179 | Mar 2003 | WO |
WO 2004028399 | Apr 2004 | WO |
WO 2006007389 | Jan 2006 | WO |
WO 2006086434 | Aug 2006 | WO |
WO 2006116558 | Nov 2006 | WO |
WO 20060128193 | Nov 2006 | WO |
WO 2007047488 | Apr 2007 | WO |
WO 2008029296 | Mar 2008 | WO |
WO 2009091509 | Jul 2009 | WO |
WO 2010006627 | Jan 2010 | WO |
WO 2010027485 | Mar 2010 | WO |
WO 2010045297 | Apr 2010 | WO |
WO 2010057262 | May 2010 | WO |
WO 2011069048 | Jun 2011 | WO |
WO 2011144351 | Nov 2011 | WO |
WO 2012011108 | Jan 2012 | WO |
WO 2012036740 | Mar 2012 | WO |
WO 2012048035 | Apr 2012 | WO |
WO 2013059747 | Apr 2013 | WO |
WO 2013072496 | May 2013 | WO |
WO 2013078497 | Jun 2013 | WO |
WO 2013114214 | Aug 2013 | WO |
WO 2013175468 | Nov 2013 | WO |
WO 2014115149 | Jul 2014 | WO |
WO 2014144937 | Sep 2014 | WO |
WO 2014164364 | Oct 2014 | WO |
WO 2016016899 | Feb 2016 | WO |
WO 2016098104 | Jun 2016 | WO |
WO 2016125160 | Aug 2016 | WO |
WO 2016125160 | Aug 2016 | WO |
WO 2016150806 | Sep 2016 | WO |
WO 2018025260 | Feb 2018 | WO |
WO 2018025263 | Feb 2018 | WO |
WO 2018029680 | Feb 2018 | WO |
WO 2018039631 | Mar 2018 | WO |
WO 2018112429 | Jun 2018 | WO |
WO 2018118717 | Jun 2018 | WO |
WO 2018131042 | Jul 2018 | WO |
WO 2018131043 | Jul 2018 | WO |
WO 2019027507 | Feb 2019 | WO |
WO 2019195860 | Oct 2019 | WO |
WO 2020167677 | Aug 2020 | WO |
Entry |
---|
International Search Report dated Dec. 5, 2011, by the United States Patent and Trademark Office in PCT/IL2011/000582 (3 pages). |
International Search Report dated Mar. 27, 2018, by the European Patent Office in PCT/IL2017/050849 (5 pages). |
International Search Report dated May 30, 2016, by the European Patent Office in PCT/IL2016/050125 (6 pages). |
International Search Report dated Nov. 24, 2017, by the European Patent Office in PCT/IL2017/050873 (5 pages). |
International Search Report dated Oct. 27, 2015, by the European Patent Office in PCT/IL2015/050792 (3 pages). |
International Search Report dated Sep. 4, 2014, by the European Patent Office in PCT/IL2014/050087 (6 pages). |
Written Opinion of the International Searching Authority issued by the United States Patent and Trademark Office in PCT/IL2011/000582 (12 pages). |
Written Opinion of the International Searching Authority issued by the European Patent Office in PCT/IL2017/050849 (10 pages). |
Written Opinion of the International Searching Authority issued by the European Patent Office in PCT/IL2016/050125 (7 pages). |
Written Opinion of the International Searching Authority issued by the European Patent Office in PCT/IL2014/050087 (10 pages). |
Written Opinion of the International Searching Authority issued by the European Patent Office in PCT/IL2015/050792 (5 pages). |
Written Opinion of the International Searching Authority issued by the European Patent Office in PCT/IL2017/050873 (12 pages). |
Sundermann, Simon H. et al., Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design, 42 European Journal of Cardio-Thoracic Surgery, Jun. 27, 2012, at e48 (5 pages). |
Symetis S.A., Clinical Investigation Plan for ACURATE Neo™ TA Delivery System, Protocol Jan. 2015, ver. 2, ClinicalTrials.gov Identifier NCT02950428, Sep. 8, 2015 (76 pages). |
Tchetche, Didier et al., New-generation TAVI devices: description and specifications, 10 Eurolntervention (Supplement), Sep. 2014, at U90 (11 pages). |
Batista, Randas J. V. et al., Partial Left Ventriculectomy to Treat End-Stage Heart Disease, 64 Annals Thoracic Surgery 634-38 (1997) (5 pages). |
Beall, Jr., Arthur C. et al., Clinical Experience with a Dacron Velour-Covered Teflon-Disc Mitral-Valve Prosthesis, 5 Annals Thoracic Surgery 402-10 (1968) (9 pages). |
Fucci, Carlo et al., Improved Results with Mitral Valve Repair Using New Surgical Techniques, 9 Eur. J. Cardiothoracic Surgery 621-27 (1995) (7 pages). |
Maisano, Francesco et al., The Edge-To-Edge Technique: A Simplified Method to Correct Mitrel Insufficiency, 13 Eur. J. Cardiothoracic Surgery 240-46 (1998) (7 pages). |
Stone, Gregg W. et al., Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitrel Valve Repair and Replacement: Part 1: Clinical Trial Design Principles, 66 J. Am. C. Cardiology 278-307 (2015) (30 pages). |
Poirier, Nancy et al., A Novel Repair for Patients with Atrioventricular Septal Defect Requiring Reoperation for Left Atrioventricular Valve Regurgitation, 18 Eur. J. Cardiothoracic Surgery 54-61 (2000) (8 pages). |
Ando, Tomo et al., Iatrogenic Ventricular Septal Defect Following Transcatheter Aortic Valve Replacement: A Systematic Review, 25 Heart, Lung, and Circulation 968-74 (2016) (7 pages). |
Urina, Marina et al., Transseptal Transcatheter Mitral Valve Replacement Using Balloon-Expandable Transcatheter Heart Valves, JACC: Cardiovascular Interventions 1905-19 (2017) (15 pages). |
Edwards Lifesciences Corp.v. Cardiovalve Ltd. , IPR2021-00383, Exhibit 1014: Transcript of proceedings held May 20, 2021 (May 26, 2021) (21 pages). |
Edwards Lifesciences Corp.v. Cardiovalve Ltd. , IPR2021-00383, Exhibit 1015: Facilitate, Merriam-Webster.com, https://www. www.merriam-webster.com/dictionary/facilitate (accessed May 27, 2021) (5 pages). |
Edwards Lifesciences Corp.v. Cardiovalve Ltd. , IPR2021-00383, Paper 12: Petitioners' Authorized Reply to Patent Owner's Preliminary Response (May 27, 2021) (9 pages). |
Edwards Lifesciences Corp.v. Cardiovalve Ltd. , IPR2021-00383, Paper 13: Patent Owner's Authorized Surreply to Petitioner's Reply to Patent Owner's Preliminary Response (Jun. 4, 2021) (8 pages). |
Edwards Lifesciences Corp.v. Cardiovalve Ltd. , IPR2021-00383, Paper 16: Institution Decision (Jul. 20, 2021) (51 pages). |
Edwards Lifesciences Corporation and Edwards Lifesciences LLC, Petitioner v. Cardiovalve Ltd. , Patent Owner, Case No. IPR2021-00383, U.S. Pat. No. 10,226,341, Deposition of Dr. Ivan Vesely, Ph D., Washington, D.C., Sep. 22, 2021, reported by Mary Ann Payonk, Job No. 199935, TSG Reporting-Worldwide, Cardiovalve Exhibit 2010, 170 pgs. |
Fann, James I., et al., “Beating Heart Catheter-Based Edge-to-Edge Mitral Valve Procedure in a Porcine Model, Efficacy and Hearing Response,” Circulation, 110:988-993, originally published Aug. 9, 2004, 6 pgs. |
Feldman, Ted et al., “Percutaneous Mitral Valve Repair Using the Edge-to-Edge Technique, Six-Month Results of the EVEREST Phase I Clinical Trial,” J Am Coll Cardiol, 2005; vol. 46, No. 11, 2134-40, available online Oct. 19, 2005, 7 pgs. |
Feldman, Ted et al., “Percutaneous Mitral Repair With the MitraClip System, Safety and Midterm Durability in the Initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) Cohort,” J Am Coll Cardiol, 2009;54:686-94, available online Aug. 11, 2009, 9 pgs. |
Feldman, Ted et al., “Percutaneous Mitral Leaflet Repair: MitraClip® Therapy for Mitral Regurgitation,” Informa Healthcare, ©2012, ISBN: 13:978-1-84184-966-9, Version Date Jan. 16, 2005, 8 pgs. |
Fucci, C. et al., “Improved Results with Mitral Valve Repair Using New Surgical Techniques,” EurJ Cardio-thorac Surg, © Springer-Verlag 1995, EurJ Cardio-thorac Surg, (1995) 9: 621-627, published Nov. 1, 1995, 7 pgs. |
Maisano, Francesco et al., “The Evolution From Surgery to Percutaneous Mitral Valve Interventions, The Role of the Edge-to-Edge Technique,” J Am Coll Cardiol, 2011;58:2174-82, available online Nov. 8, 2011, 9 pgs. |
Maisano, F. et al., “The Edge-to-Edge Technique: A Simplified Method to Correct Mitral Insufficiency,” European Journal of Cardio-thoracic Surgery 13 (1998) 240-246, published Mar. 1, 1998, 7 pgs. |
Edwards Lifesciences Corporation and Edwards Lifesciences LLC, Petitioner v. Cardiovalve Ltd. , Patent Owner, IPR2021-00383, U.S. Pat. No. 10,226,341, Patent Owner's Response Pursuant to 37 C.F.R. § 42.120, 75 pgs. |
Edwards Lifesciences Corporation and Edwards Lifesciences LLC, Petitioner v. Cardiovalve Ltd. , Patent Owner, IPR2021-00383, U.S. Pat. No. 10,226,341, Second Declaration of Dr. Michael Sacks, Cardiovalve Exhibit 2014, 28 pgs. |
Edwards Lifesciences Corporation and Edwards Lifesciences LLC, Petitioner v. Cardiovalve Ltd. , Patent Owner, IPR2021-00383, U.S. Pat. No. 10,226,341, Patent Owner's Contingent Motion to Amend under 37 C.F.R. §42.121, 35 pgs. |
Edwards Lifesciences Corp.v. Cardiovalve Ltd. , IPR2021-00383, Paper 10: Decision Granting Institution Of Inter Partes Review (Dec. 10, 2021) (42 pages). |
Edwards Lifesciences Corp.v. Cardiovalve Ltd. , IPR2021-00383, Petitioners' Opposition to Patent Owner's Contingent Motion to Amend (Jan. 5, 2022) (32 pages). |
Edwards Lifesciences Corp.v. Cardiovalve Ltd. , IPR2021-00383, Petitioners' Reply to Patent Owner's Response (Jan. 5, 2022) (41 pages). |
Number | Date | Country | |
---|---|---|---|
20190083263 A1 | Mar 2019 | US |
Number | Date | Country | |
---|---|---|---|
62560384 | Sep 2017 | US |